Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tarsus Pharmaceuticals, Inc.

TARS Clue Score56
United States Fiscal year ends December CIK 0001819790
73.16
+1.30%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
73.16 on 9 Oct 2026
91 73 56 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $70.34 14 Oct 2025 $69.83 15 Oct 2025 $74.95 16 Oct 2025 $74.97 17 Oct 2025 $72.93 20 Oct 2025 $71.19 21 Oct 2025 $70.82 22 Oct 2025 $68.70 23 Oct 2025 $68.32 24 Oct 2025 $66.06 27 Oct 2025 $68.17 28 Oct 2025 $67.56 29 Oct 2025 $67.52 30 Oct 2025 $68.96 31 Oct 2025 $68.81 3 Nov 2025 $69.79 4 Nov 2025 $71.50 5 Nov 2025 $68.20 6 Nov 2025 $68.09 7 Nov 2025 $68.25 10 Nov 2025 $72.79 11 Nov 2025 $75.64 12 Nov 2025 $74.81 13 Nov 2025 $72.53 14 Nov 2025 $72.92 17 Nov 2025 $74.17 18 Nov 2025 $76.97 19 Nov 2025 $77.11 20 Nov 2025 $76.98 21 Nov 2025 $79.66 24 Nov 2025 $82.11 25 Nov 2025 $78.88 26 Nov 2025 $80.50 28 Nov 2025 $79.96 1 Dec 2025 $79.97 2 Dec 2025 $79.44 3 Dec 2025 $81.88 4 Dec 2025 $81.83 5 Dec 2025 $81.77 8 Dec 2025 $82.23 9 Dec 2025 $79.55 10 Dec 2025 $81.32 11 Dec 2025 $81.70 12 Dec 2025 $81.35 15 Dec 2025 $80.48 16 Dec 2025 $78.28 17 Dec 2025 $77.77 18 Dec 2025 $77.48 19 Dec 2025 $81.40 22 Dec 2025 $81.98 23 Dec 2025 $82.13 24 Dec 2025 $82.51 26 Dec 2025 $81.78 29 Dec 2025 $81.97 30 Dec 2025 $82.33 31 Dec 2025 $81.88 2 Jan 2026 $80.77 5 Jan 2026 $79.75 6 Jan 2026 $79.88 7 Jan 2026 $78.08 8 Jan 2026 $78.21 9 Jan 2026 $76.87 12 Jan 2026 $75.53 13 Jan 2026 $75.73 14 Jan 2026 $75.23 15 Jan 2026 $73.65 16 Jan 2026 $71.14 20 Jan 2026 $70.93 21 Jan 2026 $71.17 22 Jan 2026 $71.03 23 Jan 2026 $68.36 26 Jan 2026 $67.94 27 Jan 2026 $68.15 28 Jan 2026 $64.18 29 Jan 2026 $65.71 30 Jan 2026 $64.54 2 Feb 2026 $65.93 3 Feb 2026 $66.86 4 Feb 2026 $63.51 5 Feb 2026 $61.99 6 Feb 2026 $64.62 9 Feb 2026 $65.50 10 Feb 2026 $65.91 11 Feb 2026 $65.39 12 Feb 2026 $63.25 13 Feb 2026 $60.78 17 Feb 2026 $62.78 18 Feb 2026 $63.27 19 Feb 2026 $65.54 20 Feb 2026 $66.61 23 Feb 2026 $69.59 24 Feb 2026 $75.01 25 Feb 2026 $72.65 26 Feb 2026 $75.87 27 Feb 2026 $75.52 2 Mar 2026 $77.43 3 Mar 2026 $76.55 4 Mar 2026 $76.20 5 Mar 2026 $74.90 6 Mar 2026 $73.26 9 Mar 2026 $74.49 10 Mar 2026 $73.02 11 Mar 2026 $69.88 12 Mar 2026 $68.17 13 Mar 2026 $67.96 16 Mar 2026 $68.90 17 Mar 2026 $69.79 18 Mar 2026 $68.24 19 Mar 2026 $66.75 20 Mar 2026 $64.51 23 Mar 2026 $64.13 24 Mar 2026 $63.15 25 Mar 2026 $66.96 26 Mar 2026 $67.20 27 Mar 2026 $66.25 30 Mar 2026 $66.92 31 Mar 2026 $70.15 1 Apr 2026 $70.22 2 Apr 2026 $70.12 6 Apr 2026 $70.19 7 Apr 2026 $68.76 8 Apr 2026 $71.89 9 Apr 2026 $72.43 10 Apr 2026 $72.56 13 Apr 2026 $72.65 14 Apr 2026 $73.81 15 Apr 2026 $71.80 16 Apr 2026 $67.72 17 Apr 2026 $67.24 20 Apr 2026 $65.97 21 Apr 2026 $64.51 22 Apr 2026 $63.48 23 Apr 2026 $60.97 24 Apr 2026 $61.45 27 Apr 2026 $60.93 28 Apr 2026 $62.09 29 Apr 2026 $60.67 30 Apr 2026 $63.61 1 May 2026 $63.62 4 May 2026 $64.57 5 May 2026 $65.04 6 May 2026 $64.76 7 May 2026 $63.96 8 May 2026 $61.21 11 May 2026 $59.65 12 May 2026 $59.83 13 May 2026 $64.66 14 May 2026 $65.18 15 May 2026 $62.48 18 May 2026 $62.82 19 May 2026 $61.29 20 May 2026 $64.79 21 May 2026 $63.48 22 May 2026 $62.26 26 May 2026 $61.16 27 May 2026 $60.06 28 May 2026 $59.54 29 May 2026 $59.40 1 Jun 2026 $58.93 2 Jun 2026 $57.41 3 Jun 2026 $58.76 4 Jun 2026 $60.34 5 Jun 2026 $59.28 8 Jun 2026 $59.64 9 Jun 2026 $61.55 10 Jun 2026 $61.27 11 Jun 2026 $62.61 12 Jun 2026 $61.95 15 Jun 2026 $61.85 16 Jun 2026 $60.80 17 Jun 2026 $62.55 18 Jun 2026 $63.16 22 Jun 2026 $63.56 23 Jun 2026 $66.17 24 Jun 2026 $67.11 25 Jun 2026 $64.34 26 Jun 2026 $62.92 29 Jun 2026 $61.26 30 Jun 2026 $62.94 1 Jul 2026 $60.89 2 Jul 2026 $65.44 6 Jul 2026 $67.05 7 Jul 2026 $70.55 8 Jul 2026 $67.73 9 Jul 2026 $64.14 10 Jul 2026 $58.14 13 Jul 2026 $59.31 14 Jul 2026 $56.11 15 Jul 2026 $57.50 16 Jul 2026 $57.69 17 Jul 2026 $59.85 20 Jul 2026 $56.25 21 Jul 2026 $57.26 22 Jul 2026 $57.58 23 Jul 2026 $58.58 24 Jul 2026 $58.66 27 Jul 2026 $60.12 28 Jul 2026 $58.95 29 Jul 2026 $58.52 30 Jul 2026 $59.54 31 Jul 2026 $59.04 3 Aug 2026 $61.32 4 Aug 2026 $61.11 5 Aug 2026 $61.29 6 Aug 2026 $65.33 7 Aug 2026 $64.79 10 Aug 2026 $67.76 11 Aug 2026 $69.46 12 Aug 2026 $70.02 13 Aug 2026 $68.88 14 Aug 2026 $69.20 17 Aug 2026 $70.62 18 Aug 2026 $71.03 19 Aug 2026 $73.44 20 Aug 2026 $71.49 21 Aug 2026 $72.70 24 Aug 2026 $72.81 25 Aug 2026 $71.45 26 Aug 2026 $70.65 27 Aug 2026 $71.92 28 Aug 2026 $71.76 31 Aug 2026 $74.24 1 Sep 2026 $74.05 2 Sep 2026 $82.76 3 Sep 2026 $83.21 4 Sep 2026 $90.78 8 Sep 2026 $87.22 9 Sep 2026 $82.77 10 Sep 2026 $81.12 11 Sep 2026 $79.31 14 Sep 2026 $79.95 15 Sep 2026 $78.23 16 Sep 2026 $77.64 17 Sep 2026 $79.03 18 Sep 2026 $78.09 21 Sep 2026 $77.46 22 Sep 2026 $77.08 23 Sep 2026 $74.29 24 Sep 2026 $75.96 25 Sep 2026 $75.69 28 Sep 2026 $76.81 29 Sep 2026 $76.69 30 Sep 2026 $78.61 1 Oct 2026 $75.46 2 Oct 2026 $73.00 5 Oct 2026 $74.46 6 Oct 2026 $74.11 7 Oct 2026 $73.61 8 Oct 2026 $72.22 9 Oct 2026 $73.16 LINK WILLIAM J PHD Director Sold on a plan $846.86K 15 Dec 2025 · at $81.07 · 100% of stake LINK WILLIAM J PHD Director Sold on a plan $1.02M 15 Dec 2025 · at $81.43 · 8.8% of stake Lin Elizabeth Yeu Chief Medical Officer Sold at will $165.20K 16 Dec 2025 · at $79.50 · 8.7% of stake Whitfield Dianne C. Chief Human Resources Officer Sold on a plan $592.50K 16 Dec 2025 · at $80.10 · 16.0% of stake Azamian Bobak R. President/CEO and Board Chair Sold on a plan $495.09K 24 Dec 2025 · at $82.51 · 0.7% of stake Whitfield Dianne C. Chief Human Resources Officer Sold on a plan $1.26M 2 Jan 2026 · at $80.67 · 40.0% of stake Neervannan Seshadri Chief Operating Officer Sold on a plan $641.42K 4 Mar 2026 · at $76.67 · 10.6% of stake LINK WILLIAM J PHD Director Sold on a plan $859.82K 16 Mar 2026 · at $68.79 · 9.7% of stake Lin Elizabeth Yeu Chief Medical Officer Sold at will $26.03K 17 Mar 2026 · at $69.42 · 1.5% of stake Farrow Jeffrey S See Remarks Sold at will $146.55K 17 Mar 2026 · at $69.42 · 4.2% of stake Neervannan Seshadri Chief Operating Officer Sold at will $216.94K 17 Mar 2026 · at $69.42 · 3.2% of stake Whitfield Dianne C. Chief Human Resources Officer Sold at will $279.69K 17 Mar 2026 · at $69.42 · 8.5% of stake Wahl Bryan General Counsel Sold at will $283.51K 17 Mar 2026 · at $69.42 · 5.3% of stake Mottiwala Aziz Chief Commercial Officer Sold at will $297.53K 17 Mar 2026 · at $69.42 · 5.8% of stake Azamian Bobak R. President/CEO and Board Chair Sold at will $761.68K 17 Mar 2026 · at $69.42 · 16.1% of stake Lin Elizabeth Yeu Chief Medical Officer Sold at will $26.04K 18 Mar 2026 · at $68.71 · 1.6% of stake Farrow Jeffrey S See Remarks Sold at will $146.56K 18 Mar 2026 · at $68.71 · 4.5% of stake Neervannan Seshadri Chief Operating Officer Sold at will $248.04K 18 Mar 2026 · at $68.71 · 3.8% of stake Whitfield Dianne C. Chief Human Resources Officer Sold at will $279.72K 18 Mar 2026 · at $68.71 · 9.4% of stake Wahl Bryan General Counsel Sold at will $283.43K 18 Mar 2026 · at $68.71 · 5.7% of stake Mottiwala Aziz Chief Commercial Officer Sold at will $297.51K 18 Mar 2026 · at $68.71 · 6.2% of stake Azamian Bobak R. President/CEO and Board Chair Sold at will $801.64K 18 Mar 2026 · at $68.71 · 20.4% of stake Lin Elizabeth Yeu Chief Medical Officer Sold at will $26.13K 19 Mar 2026 · at $67.00 · 1.6% of stake Farrow Jeffrey S See Remarks Sold at will $146.46K 19 Mar 2026 · at $67.00 · 4.8% of stake Whitfield Dianne C. Chief Human Resources Officer Sold at will $279.66K 19 Mar 2026 · at $67.00 · 10.6% of stake Wahl Bryan General Counsel Sold at will $283.48K 19 Mar 2026 · at $67.00 · 6.2% of stake Mottiwala Aziz Chief Commercial Officer Sold at will $297.48K 19 Mar 2026 · at $67.00 · 6.7% of stake Neervannan Seshadri Chief Operating Officer Sold at will $307.46K 19 Mar 2026 · at $67.00 · 5.1% of stake Azamian Bobak R. President/CEO and Board Chair Sold at will $801.59K 19 Mar 2026 · at $67.00 · 26.4% of stake Neervannan Seshadri Chief Operating Officer Sold on a plan $199.52K 20 Mar 2026 · at $66.75 · 3.5% of stake Goodrich Katherine Director Sold on a plan $183.38K 15 Jun 2026 · at $62.08 · 57.0% of stake LINK WILLIAM J PHD Director Sold on a plan $776.50K 15 Jun 2026 · at $62.12 · 10.5% of stake Farrow Jeffrey S See Remarks Sold at will $877.44K 16 Jun 2026 · at $60.95 · 20.2% of stake Azamian Bobak R. President/CEO and Board Chair Sold on a plan $615.49K 17 Jun 2026 · at $61.55 · 1.2% of stake Lin Elizabeth Yeu Chief Medical Officer Sold on a plan $339.83K 1 Sep 2026 · at $73.86 · 19.7% of stake Lin Elizabeth Yeu Chief Medical Officer Sold on a plan $127.20K 2 Sep 2026 · at $80.00 · 25.0% of stake Lin Elizabeth Yeu Chief Medical Officer Sold on a plan $430.96K 2 Sep 2026 · at $80.00 · 28.8% of stake Azamian Bobak R. President/CEO and Board Chair Sold on a plan $800.60K 2 Sep 2026 · at $80.06 · 1.2% of stake Lin Elizabeth Yeu Chief Medical Officer Sold on a plan $278.25K 4 Sep 2026 · at $87.50 · 66.7% of stake Neervannan Seshadri Chief Operating Officer Sold on a plan $387.94K 4 Sep 2026 · at $85.00 · 5.5% of stake Azamian Bobak R. President/CEO and Board Chair Sold on a plan $905.60K 4 Sep 2026 · at $90.56 · 1.2% of stake Lin Elizabeth Yeu Chief Medical Officer Sold on a plan $942.64K 4 Sep 2026 · at $87.50 · 80.9% of stake LINK WILLIAM J PHD Director Sold on a plan $979.74K 15 Sep 2026 · at $78.38 · 11.7% of stake
0 buys23 sales at will20 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$451.36M
Net income
$66.42M
Free cash flow
$22.31M
Operating margin
-15.7%
Net margin
-14.7%
Return on equity
-19.3%
Return on capital
-13.5%
Debt to equity
0.21
Revenue growth, 1 yr
146.7%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -27M FY20 Fiscal year 2020 Revenue $0.00 Net income $26.81M Margin n/a 57M -14M FY21 Fiscal year 2021 Revenue $57.03M Net income $13.83M Margin -24.2% 26M -62M FY22 Fiscal year 2022 Revenue $25.82M Net income $62.09M Margin -240.5% · growth -54.7% 17M -136M FY23 Fiscal year 2023 Revenue $17.45M Net income $135.89M Margin -778.9% · growth -32.4% 183M -116M FY24 Fiscal year 2024 Revenue $182.95M Net income $115.55M Margin -63.2% · growth +948.6% 451M -66M FY25 Fiscal year 2025 Revenue $451.36M Net income $66.42M Margin -14.7% · growth +146.7%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
15 Sep 2026 LINK WILLIAM J PHD
Director
Sold on a plan $979.74K 11.7%
4 Sep 2026 Lin Elizabeth Yeu
Chief Medical Officer
Sold on a plan $942.64K 80.9%
4 Sep 2026 Azamian Bobak R.
President/CEO and Board Chair
Sold on a plan $905.60K 1.2%
4 Sep 2026 Neervannan Seshadri
Chief Operating Officer
Sold on a plan $387.94K 5.5%
4 Sep 2026 Lin Elizabeth Yeu
Chief Medical Officer
Sold on a plan $278.25K 66.7%
2 Sep 2026 Azamian Bobak R.
President/CEO and Board Chair
Sold on a plan $800.60K 1.2%